1. Home
  2. MBUU vs RCKT Comparison

MBUU vs RCKT Comparison

Compare MBUU & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Malibu Boats Inc.

MBUU

Malibu Boats Inc.

HOLD

Current Price

$26.05

Market Cap

560.3M

Sector

Industrials

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.47

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBUU
RCKT
Founded
1982
1999
Country
United States
United States
Employees
N/A
202
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.3M
534.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
MBUU
RCKT
Price
$26.05
$3.47
Analyst Decision
Hold
Buy
Analyst Count
8
14
Target Price
$32.43
$29.73
AVG Volume (30 Days)
309.3K
4.2M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
127.74
N/A
EPS
N/A
N/A
Revenue
$807,561,000.00
N/A
Revenue This Year
$1.44
N/A
Revenue Next Year
$10.67
$51.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.07
$2.19
52 Week High
$39.65
$8.26

Technical Indicators

Market Signals
Indicator
MBUU
RCKT
Relative Strength Index (RSI) 40.27 36.23
Support Level $24.43 $3.43
Resistance Level $34.66 $3.49
Average True Range (ATR) 0.97 0.39
MACD 0.24 -0.15
Stochastic Oscillator 41.30 3.69

Price Performance

Historical Comparison
MBUU
RCKT

About MBUU Malibu Boats Inc.

Malibu Boats is a designer and manufacturer of power boats in the United States. It is a market leader in performance sport boats, sold under its Malibu and Axis brands. It acquired Cobalt Boats, a producer of sterndrive boats, in 2017, and Pursuit Boats, which makes high end offshore and outboard motorboats in 2018. In 2021, it purchased Maverick Boat Group, a seller of flat fishing boats, with exposure to bay, dual console, and center console boats. Malibu has also expanded into boat trailers and accessories, and in 2020, began producing its own engines for its performance sport boats.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: